NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) —
iCAD, Inc.
(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on Wednesday, May 11.
|
Wednesday, May 11th at 4:30 PM ET |
|
| Domestic: | 888-506-0062 |
| International: | 973-528-0011 |
| Conference ID: | 728427 |
| Webcast: |
https://www.webcaster4.com/Webcast/Page/2879/45416 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit
www.icadmed.com
.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
[email protected]
Investor Inquiries:
iCAD Investor Relations
[email protected]
